GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DreamCIS INC (XKRX:223250) » Definitions » Institutional Ownership

DreamCIS (XKRX:223250) Institutional Ownership : 0.08% (As of Jun. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is DreamCIS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DreamCIS's institutional ownership is 0.08%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DreamCIS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DreamCIS's Float Percentage Of Total Shares Outstanding is 0.00%.


DreamCIS Institutional Ownership Historical Data

The historical data trend for DreamCIS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DreamCIS Institutional Ownership Chart

DreamCIS Historical Data

The historical data trend for DreamCIS can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-05-31
Institutional Ownership 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08

DreamCIS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


DreamCIS (XKRX:223250) Business Description

Traded in Other Exchanges
N/A
Address
130, Sajik-ro, Jongno-gu, Jeokseon-Hyundai Building, 10th Floor, Seoul, KOR
DreamCIS INC operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.

DreamCIS (XKRX:223250) Headlines

No Headlines